David C Wilson
Overview
Explore the profile of David C Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
164
Citations
9094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Withey K, Brougham M, Paciarotti I, McKenzie J, Wilson D, Revuelta Iniesta R
Pediatr Blood Cancer
. 2025 Mar;
:e31645.
PMID: 40055871
Background: Given the limited research on folate and ferritin status in children with cancer undergoing treatment, we investigated the prevalence of abnormalities and their impact on clinical outcomes and treatment...
2.
Kaj-Carbaidwala B, Fevery J, Adler D, Bergquist A, de Ridder L, Deneau M, et al.
J Pediatr Gastroenterol Nutr
. 2024 Dec;
80(3):450-454.
PMID: 39704261
Primary sclerosing cholangitis (PSC) is a risk factor for cholangiocarcinoma. When a child is diagnosed with both PSC and inflammatory bowel disease (IBD), evidence-based information on counseling families and risk...
3.
Scott G, Wands D, Wilson D, Hansen R, Chalmers I
Inflamm Bowel Dis
. 2024 Dec;
PMID: 39671376
Background: The 2021 ECCO-ESPGHAN guideline on the medical management of pediatric Crohn's disease promotes early risk stratification and top-down anti-TNF for patients deemed high risk of severe disease course. Aims:...
4.
Fioretti M, Gianolio L, Armstrong K, Rabone R, Henderson P, Wilson D, et al.
J Pediatr Gastroenterol Nutr
. 2024 Dec;
80(2):300-307.
PMID: 39648957
Objectives: The aim of our study was to assess the effectiveness and side-effect profile of a combination of azithromycin and metronidazole (CD AZCRO) as alternative induction therapy for 8 weeks...
5.
Wands D, Gianolio L, Cameron F, Hansen R, Russell R, Wilson D
Inflamm Bowel Dis
. 2024 Sep;
31(2):313-320.
PMID: 39321100
Background: Given the paucity of long-term longitudinal data for inflammatory bowel disease type unclassified (IBDU), we aimed to clarify IBDU disease course and reclassification rate by presenting nationwide data with...
6.
Wilson D, Paul J, Ramola A, Filho C
Waste Manag Res
. 2024 Jul;
42(10):860-872.
PMID: 39068519
Numbers do matter; the Intergovernmental Panel on Climate Change (IPCC)'s 2010 data that the waste sector is responsible for just 3% of global greenhouse gas (GHG) emissions has led to...
7.
Pujol-Muncunill G, Navas-Lopez V, Ledder O, Cohen S, Lekar M, Turner D, et al.
Eur J Pediatr
. 2024 May;
183(8):3253-3262.
PMID: 38700692
Ustekinumab is an effective therapy for adult Crohn's disease (CD), but data in paediatric CD patients are scarce. The aim of the study was to describe the real-life effectiveness and...
8.
Hope E, Kuronen-Stewart C, Wilson D, Henderson P, Clark C
J Pediatr Surg
. 2023 Nov;
59(2):230-234.
PMID: 37981545
Aim: Biologic therapies have been associated with reduced rate of colectomy in ulcerative colitis (UC) in adults, but data are limited in paediatric-onset UC. Our aim was to define the...
9.
Uhlig H, Booth C, Cho J, Dubinsky M, Griffiths A, Grimbacher B, et al.
Nat Rev Gastroenterol Hepatol
. 2023 Oct;
20(12):810-828.
PMID: 37789059
Owing to advances in genomics that enable differentiation of molecular aetiologies, patients with monogenic inflammatory bowel disease (mIBD) potentially have access to genotype-guided precision medicine. In this Expert Recommendation, we...
10.
Wilson D
Waste Manag Res
. 2023 Sep;
41(12):1754-1813.
PMID: 37732707
Improving waste and resource management (WaRM) around the world can halve the weight of plastics entering the oceans, significantly mitigate global heating and contribute directly to 12 of 17 sustainable...